TUBEROUS SCLEROSIS COMPLEX (TSC)
Clinical trials for TUBEROUS SCLEROSIS COMPLEX (TSC) explained in plain language.
Never miss a new study
Get alerted when new TUBEROUS SCLEROSIS COMPLEX (TSC) trials appear
Sign up with your email to follow new studies for TUBEROUS SCLEROSIS COMPLEX (TSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to tame Hard-to-Treat cancers
Disease control Recruiting nowThis early-phase study tests a new drug called Sapu003 in 27 adults with advanced solid tumors (like breast, kidney, or liver cancer) that are sensitive to mTOR-targeted therapy. The main goal is to find the safest dose and check for side effects. Participants receive Sapu003 wee…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX (TSC)
Phase: PHASE1 • Sponsor: SAPU NANO (US) LLC • Aim: Disease control
Last updated May 17, 2026 05:05 UTC
-
Cannabis extract shows promise for Hard-to-Treat seizures in rare disease
Disease control Recruiting nowThis study tests a full-spectrum cannabis extract (YCJ-01) to see if it can reduce seizures in people with tuberous sclerosis complex (TSC) whose epilepsy does not respond to standard treatments. About 84 participants aged 2 to 65 will receive either the extract or a placebo. The…
Matched conditions: TUBEROUS SCLEROSIS COMPLEX (TSC)
Phase: PHASE3 • Sponsor: Oils4Cure • Aim: Disease control
Last updated May 11, 2026 20:53 UTC